Silo Pharma, Inc. (SILO): R&D Expense
$2.16M
Year ended 2025-12-31
$2.16M
Trailing 12 months to 2026-06-30
+18.9%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.16M | -8.8% | 2026-03-27, From 2025-01-01 |
| 2024-12-31 | $2.37M | +180.2% | 2026-03-27, From 2024-01-01 |
| 2023-12-31 | $845.1K | -34.3% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $1.29M | +85.4% | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | $693.9K | n/m | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | $26.2K | n/a | 2022-03-28, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $2.16M | -8.8% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $54.21M | -28.3% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $37.80M | +29.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $10.75M | -16.6% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $50.08M | +105.0% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $21.12M | -29.7% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $5.44M | -14.8% |
| iBio, Inc. (IBIO) | 2026-06-30 | $19.64M | +136.3% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $1.80M | -19.0% |
Compare SILO, INO, CNTB, IXHL side by side · Screen every company in Pharmaceutical Preparations ↗